Figure 4
Defective positive selection in the absence of RhoH. (A) Thymocytes of 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR, either expressing or not expressing RhoH, were analyzed for the expression of CD4 and CD8 by FACS (upper panel). Quantification of absolute numbers of thymocyte subpopulations (lower panel). *P < .05; **P < .01; ***P < .001. Error bars indicate the standard deviation (n [control]/RhoH−/−]: 3/4). (B) Thymocytes of 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR, either expressing or not expressing RhoH, were gated for lineage-negative (B220, CD4, CD8, NK1.1, Mac1, Gr-1, Ter119) cells and analyzed for the expression of CD25 and CD44. DN1, CD25−CD44+; DN2, CD25+CD44+; DN3, CD25+CD44−; DN4, CD25−CD44−; upper panel). Quantification of absolute numbers of thymocyte subpopulations (lower panel; *P < .05. Error bars indicate the standard deviation (n [control]/RhoH−/−]: 3/4). (C) Decreased amount of Vα2+ DN thymocytes in 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR in the absence of RhoH. *P < .05; **P < .01. Error bars indicate the standard deviation (n [control]/RhoH−/−]: 4/4). (D) Increased amount of CD5low thymocytes in 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR in the absence of RhoH. **P < .01; ***P < .001; Error bars indicate the standard deviation (n [control]/RhoH−/−]: 4/4). (E) Decreased amount of CD69high thymocytes in 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR in the absence of RhoH. *P < .05; **P < .01. Error bars indicate the standard deviation (n [control]/RhoH−/−]: 4/4).

Defective positive selection in the absence of RhoH. (A) Thymocytes of 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR, either expressing or not expressing RhoH, were analyzed for the expression of CD4 and CD8 by FACS (upper panel). Quantification of absolute numbers of thymocyte subpopulations (lower panel). *P < .05; **P < .01; ***P < .001. Error bars indicate the standard deviation (n [control]/RhoH−/−]: 3/4). (B) Thymocytes of 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR, either expressing or not expressing RhoH, were gated for lineage-negative (B220, CD4, CD8, NK1.1, Mac1, Gr-1, Ter119) cells and analyzed for the expression of CD25 and CD44. DN1, CD25CD44+; DN2, CD25+CD44+; DN3, CD25+CD44; DN4, CD25CD44; upper panel). Quantification of absolute numbers of thymocyte subpopulations (lower panel; *P < .05. Error bars indicate the standard deviation (n [control]/RhoH−/−]: 3/4). (C) Decreased amount of Vα2+ DN thymocytes in 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR in the absence of RhoH. *P < .05; **P < .01. Error bars indicate the standard deviation (n [control]/RhoH−/−]: 4/4). (D) Increased amount of CD5low thymocytes in 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR in the absence of RhoH. **P < .01; ***P < .001; Error bars indicate the standard deviation (n [control]/RhoH−/−]: 4/4). (E) Decreased amount of CD69high thymocytes in 4- to 7-week-old OT-II mice transgenic for an ovalbumin-specific TCR in the absence of RhoH. *P < .05; **P < .01. Error bars indicate the standard deviation (n [control]/RhoH−/−]: 4/4).

Close Modal

or Create an Account

Close Modal
Close Modal